# Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences

> **NCT07694310** · NA · NOT_YET_RECRUITING · sponsor: **London School of Economics and Political Science** · enrollment: 3000 (estimated)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Control
- **OTHER:** Unvalidates surrogate endpoint
- **OTHER:** Limited study population
- **OTHER:** Small magnitude of effect
- **OTHER:** Multiple uncertainties

## Key facts

- **NCT ID:** NCT07694310
- **Lead sponsor:** London School of Economics and Political Science
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-14
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07694310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07694310, "Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07694310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*